Data as of Sep 21, 2026 · Based on 3,332,371 AI responses across 10,526 prompts · See how Parse measures this
Sygnomics SPOT-AI is a personalized oncology platform that unifies diagnostics, treatment, and therapeutics using network biology and AI to improve patient outcomes. It enhances patient risk prediction and therapy matching through the Sygnomics Analytics Test (SAT), a predictive biotechnology that identifies the most effective therapies for each individual. SAT can serve as a companion diagnostic to rescue failed clinical trials, accelerate drug development, and enable repurposing of existing drugs for new indications.
Parse Score
No contexts measured yet.
Excerpts where Sygnomics appeared in the AI's answer
Sygnomics — Combines molecular diagnostics with network-biology AI to predict disease behavior and match individual patients to therapies.
Sygnomics — Its SPOT-AI platform combines patient diagnostics with AI/network biology to identify disease-driving characteristics and match patients with therapies.
